Novavax, Inc. (NVAX)
6.77
+0.03
(+0.45%)
USD |
NASDAQ |
Dec 11, 13:18
Novavax Cash from Investing (Quarterly): -136.53M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Moderna, Inc. | 700.00M |
| Merck & Co., Inc. | -283.00M |
| Sangamo Therapeutics, Inc. | -0.064M |
| Arcturus Therapeutics Holdings, Inc. | -0.1949M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 107.80M |
| Cash from Financing (Quarterly) | 42.44M |
| Free Cash Flow | -384.71M |
| Free Cash Flow Per Share (Quarterly) | 0.6516 |
| Free Cash Flow to Equity (Quarterly) | 83.14M |
| Free Cash Flow to Firm (Quarterly) | 111.25M |
| Free Cash Flow Yield | -33.55% |